Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report

By          

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1957-1961

Spandidos Publications

Access to resources Recommend Favorite

Imatinib Mesylate: A Review of Its Use in Chronic Myeloid Leukemia

By Curran M.P.   Croom K.F.   Goa K.L.  

American Journal of Cancer, Vol. 2, Iss. 6, 2003-01 ,pp. : 439-454

Adis International

Access to resources Recommend Favorite

Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid

By Zhou Hong-Sheng   Dai Min   Wei Yongqiang   Wang Qiang   Xu Na   Yin Changxin   Meng Fanyi  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1557-1559

Informa Healthcare

Access to resources Recommend Favorite

Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor

By Gerin Fethullah   Baloglu Orkun   Morgan Jeffrey   Kesari Santosh  

Journal of Neuro-Oncology, Vol. 82, Iss. 2, 2007-04 ,pp. : 227-228

Springer Publishing Company

Access to resources Recommend Favorite

In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase

By              

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 791-796

Spandidos Publications

Access to resources Recommend Favorite